Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Cardiac MR Provides Clues on Little Known Heart Muscle Condition

By HospiMedica International staff writers
Posted on 15 Dec 2010
Left ventricular noncompaction (LVNC), a cardiomyopathy about which little is fully understood is associated with heart failure (HF), stroke, and ventricular arrhythmias, according to recent findings. More...
The researchers reported that sophisticated imaging technologies reveal that developing these cardiac risks appear to progress over time in patients with LVNC.

LVNC is an inherited heart muscle condition in which the muscular wall of the left ventricle appears to be spongy and noncompacted, consisting of a meshwork of numerous muscle bands (trabeculations). However, its cause, development, clinical course, and treatment are the focus of ongoing research. As a result, the study investigators reported that the cardiology community's "understanding of the natural history of LVNC continues to evolve.”

The study's findings were presented November 2010 at the 2010 American Heart Association (AHA) scientific sessions in Chicago, IL, USA. "Our ability to detect and recognize this condition has grown considerably over the past decade, as our imaging technologies have advanced,” said study investigator William T. Katsiyiannis, MD, director of the Genetic Arrhythmia Center and a clinical cardiac electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital (Minneapolis, USA). "Fifteen years ago, the main tool to examine cardiac muscle was echocardiography, which was not as sensitive as it is today. Now, with the advent of cardiac MR [magnetic resonance], we are able to see far more detail of the heart.”

Whereas the current incidence rate of LVNC is unknown, Dr. Katsiyiannis theorized that the condition might be far more common than has been previously postulated, due to a lack of diagnosis. Earlier research had indicated complications for patients with LVNC include stroke from blood clots that form in the noncompacted tissue, the development of heart failure or left ventricular dysfunction, and the development of potentially dangerous ventricular arrhythmias.

To evaluate the association of LVNC with these traditional risk factors, the researchers assessed patients by echocardiography or cardiac MR, and diagnosed 125 patients with LVNC. Only 38.2% were diagnosed by echocardiography. "The incidence rates are unclear because echo has been the gold standard,” stated Dr. Katsiyiannis. "Echo missed the majority of patients with LVNC. Therefore, LVNC cannot be ruled out based on a normal echo.”

The study's patients had a higher than expected incidence of congestive heart failure (38.5%), left ventricular dysfunction with ejection fraction of less than 45% by cardiac MR (31.9%), and ventricular tachycardia (24.8%). Moreover, the researchers at the Minneapolis Heart Institute reported that 3.1% of patients experienced stroke and 3.1% experienced sudden death.

Dr. Katsiyiannis concluded that LVNC requires "much more research before clinical decisions are based on its diagnosis.”

Related Links:
Minneapolis Heart Institute at Abbott Northwestern Hospital



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.